Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.
Identifieur interne : 001A98 ( PubMed/Checkpoint ); précédent : 001A97; suivant : 001A99Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.
Auteurs : Tracey Disipio [Australie] ; Sheree Rye ; Beth Newman ; Sandi HayesSource :
- The Lancet. Oncology [ 1474-5488 ] ; 2013.
Descripteurs français
- KwdFr :
- Facteurs de risque, Facteurs temps, Femelle, Humains, Incidence, Lymphadénectomie (effets indésirables), Lymphoedème (anatomopathologie), Lymphoedème (épidémiologie), Mastectomie (effets indésirables), Membre supérieur (anatomopathologie), Odds ratio, Prévalence, Surpoids (épidémiologie), Tumeurs du sein (), Tumeurs du sein (diagnostic), Tumeurs du sein (épidémiologie), Évaluation des risques.
- MESH :
- anatomopathologie : Lymphoedème, Membre supérieur.
- diagnostic : Tumeurs du sein.
- effets indésirables : Lymphadénectomie, Mastectomie.
- épidémiologie : Lymphoedème, Surpoids, Tumeurs du sein.
- Facteurs de risque, Facteurs temps, Femelle, Humains, Incidence, Odds ratio, Prévalence, Tumeurs du sein, Évaluation des risques.
English descriptors
- KwdEn :
- Breast Neoplasms (diagnosis), Breast Neoplasms (epidemiology), Breast Neoplasms (surgery), Female, Humans, Incidence, Lymph Node Excision (adverse effects), Lymphedema (epidemiology), Lymphedema (pathology), Mastectomy (adverse effects), Odds Ratio, Overweight (epidemiology), Prevalence, Risk Assessment, Risk Factors, Time Factors, Upper Extremity (pathology).
- MESH :
- adverse effects : Lymph Node Excision, Mastectomy.
- diagnosis : Breast Neoplasms.
- epidemiology : Breast Neoplasms, Lymphedema, Overweight.
- pathology : Lymphedema, Upper Extremity.
- surgery : Breast Neoplasms.
- Female, Humans, Incidence, Odds Ratio, Prevalence, Risk Assessment, Risk Factors, Time Factors.
Abstract
The body of evidence related to breast-cancer-related lymphoedema incidence and risk factors has substantially grown and improved in quality over the past decade. We assessed the incidence of unilateral arm lymphoedema after breast cancer and explored the evidence available for lymphoedema risk factors.
DOI: 10.1016/S1470-2045(13)70076-7
PubMed: 23540561
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:23540561Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.</title><author><name sortKey="Disipio, Tracey" sort="Disipio, Tracey" uniqKey="Disipio T" first="Tracey" last="Disipio">Tracey Disipio</name><affiliation wicri:level="1"><nlm:affiliation>School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia. t.disipio@qut.edu.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Rye, Sheree" sort="Rye, Sheree" uniqKey="Rye S" first="Sheree" last="Rye">Sheree Rye</name></author><author><name sortKey="Newman, Beth" sort="Newman, Beth" uniqKey="Newman B" first="Beth" last="Newman">Beth Newman</name></author><author><name sortKey="Hayes, Sandi" sort="Hayes, Sandi" uniqKey="Hayes S" first="Sandi" last="Hayes">Sandi Hayes</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23540561</idno><idno type="pmid">23540561</idno><idno type="doi">10.1016/S1470-2045(13)70076-7</idno><idno type="wicri:Area/PubMed/Corpus">001C16</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C16</idno><idno type="wicri:Area/PubMed/Curation">001C16</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C16</idno><idno type="wicri:Area/PubMed/Checkpoint">001C16</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C16</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.</title><author><name sortKey="Disipio, Tracey" sort="Disipio, Tracey" uniqKey="Disipio T" first="Tracey" last="Disipio">Tracey Disipio</name><affiliation wicri:level="1"><nlm:affiliation>School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia. t.disipio@qut.edu.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Rye, Sheree" sort="Rye, Sheree" uniqKey="Rye S" first="Sheree" last="Rye">Sheree Rye</name></author><author><name sortKey="Newman, Beth" sort="Newman, Beth" uniqKey="Newman B" first="Beth" last="Newman">Beth Newman</name></author><author><name sortKey="Hayes, Sandi" sort="Hayes, Sandi" uniqKey="Hayes S" first="Sandi" last="Hayes">Sandi Hayes</name></author></analytic><series><title level="j">The Lancet. Oncology</title><idno type="eISSN">1474-5488</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (diagnosis)</term><term>Breast Neoplasms (epidemiology)</term><term>Breast Neoplasms (surgery)</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (pathology)</term><term>Mastectomy (adverse effects)</term><term>Odds Ratio</term><term>Overweight (epidemiology)</term><term>Prevalence</term><term>Risk Assessment</term><term>Risk Factors</term><term>Time Factors</term><term>Upper Extremity (pathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème (anatomopathologie)</term><term>Lymphoedème (épidémiologie)</term><term>Mastectomie (effets indésirables)</term><term>Membre supérieur (anatomopathologie)</term><term>Odds ratio</term><term>Prévalence</term><term>Surpoids (épidémiologie)</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (diagnostic)</term><term>Tumeurs du sein (épidémiologie)</term><term>Évaluation des risques</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term><term>Mastectomy</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Lymphoedème</term><term>Membre supérieur</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term><term>Mastectomie</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term><term>Overweight</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymphedema</term><term>Upper Extremity</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term><term>Surpoids</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Incidence</term><term>Odds Ratio</term><term>Prevalence</term><term>Risk Assessment</term><term>Risk Factors</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Odds ratio</term><term>Prévalence</term><term>Tumeurs du sein</term><term>Évaluation des risques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The body of evidence related to breast-cancer-related lymphoedema incidence and risk factors has substantially grown and improved in quality over the past decade. We assessed the incidence of unilateral arm lymphoedema after breast cancer and explored the evidence available for lymphoedema risk factors.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23540561</PMID><DateCreated><Year>2013</Year><Month>05</Month><Day>03</Day></DateCreated><DateCompleted><Year>2013</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2014</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-5488</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>May</Month></PubDate></JournalIssue><Title>The Lancet. Oncology</Title><ISOAbbreviation>Lancet Oncol.</ISOAbbreviation></Journal><ArticleTitle>Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>500-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1470-2045(13)70076-7</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1470-2045(13)70076-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The body of evidence related to breast-cancer-related lymphoedema incidence and risk factors has substantially grown and improved in quality over the past decade. We assessed the incidence of unilateral arm lymphoedema after breast cancer and explored the evidence available for lymphoedema risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched Academic Search Elite, Cumulative Index to Nursing and Allied Health, Cochrane Central Register of Controlled Trials (clinical trials), and Medline for research articles that assessed the incidence or prevalence of, or risk factors for, arm lymphoedema after breast cancer, published between Jan 1, 2000, and June 30, 2012. We extracted incidence data and calculated corresponding exact binomial 95% CIs. We used random effects models to calculate a pooled overall estimate of lymphoedema incidence, with subgroup analyses to assess the effect of different study designs, countries of study origin, diagnostic methods, time since diagnosis, and extent of axillary surgery. We assessed risk factors and collated them into four levels of evidence, depending on consistency of findings and quality and quantity of studies contributing to findings.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">72 studies met the inclusion criteria for the assessment of lymphoedema incidence, giving a pooled estimate of 16.6% (95% CI 13.6-20.2). Our estimate was 21.4% (14.9-29.8) when restricted to data from prospective cohort studies (30 studies). The incidence of arm lymphoedema seemed to increase up to 2 years after diagnosis or surgery of breast cancer (24 studies with time since diagnosis or surgery of 12 to <24 months; 18.9%, 14.2-24.7), was highest when assessed by more than one diagnostic method (nine studies; 28.2%, 11.8-53.5), and was about four times higher in women who had an axillary-lymph-node dissection (18 studies; 19.9%, 13.5-28.2) than it was in those who had sentinel-node biopsy (18 studies; 5.6%, 6.1-7.9). 29 studies met the inclusion criteria for the assessment of risk factors. Risk factors that had a strong level of evidence were extensive surgery (ie, axillary-lymph-node dissection, greater number of lymph nodes dissected, mastectomy) and being overweight or obese.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Our findings suggest that more than one in five women who survive breast cancer will develop arm lymphoedema. A clear need exists for improved understanding of contributing risk factors, as well as of prevention and management strategies to reduce the individual and public health burden of this disabling and distressing disorder.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">The National Breast Cancer Foundation, Australia.</AbstractText><CopyrightInformation>Copyright © 2013 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>DiSipio</LastName><ForeName>Tracey</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia. t.disipio@qut.edu.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rye</LastName><ForeName>Sheree</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Newman</LastName><ForeName>Beth</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Sandi</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Oncol</MedlineTA><NlmUniqueID>100957246</NlmUniqueID><ISSNLinking>1470-2045</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Oncol. 2013 May;14(6):442-3</RefSource><PMID Version="1">23540560</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23540561</ArticleId><ArticleId IdType="pii">S1470-2045(13)70076-7</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(13)70076-7</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li></country></list><tree><noCountry><name sortKey="Hayes, Sandi" sort="Hayes, Sandi" uniqKey="Hayes S" first="Sandi" last="Hayes">Sandi Hayes</name><name sortKey="Newman, Beth" sort="Newman, Beth" uniqKey="Newman B" first="Beth" last="Newman">Beth Newman</name><name sortKey="Rye, Sheree" sort="Rye, Sheree" uniqKey="Rye S" first="Sheree" last="Rye">Sheree Rye</name></noCountry><country name="Australie"><noRegion><name sortKey="Disipio, Tracey" sort="Disipio, Tracey" uniqKey="Disipio T" first="Tracey" last="Disipio">Tracey Disipio</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A98 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001A98 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:23540561
|texte= Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:23540561" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |